Back to search

RLT Academy

2021-1-BE02-KA220-HED-0000321242021Cooperation partnerships in higher educationongoingGood practice
Countries: BE|IT|HU|DE|AT|NL|ES|FR · Grant: €303,311
Creating new, innovative or joint curricula or coursesDevelopment of training coursesPhysical and mental health, well-being

Objectives

Our consortium had 5 main task. The first was to map the current educational landscape in Europe through a survey of universities and scientific organizations. The second was to build a training curriculum which would provide a basic and advanced course to educate medical professionals on RLT. The third was to build a website allowing to present and assess this curriculum. The fourth consisted in the formulation of policy recommendations for the wider adoption of RLT in Europe. The final task consisted in the organization of training fellowships in 4 European expert centers in RLT, consisting of short term ( one week) and long term fellowships ( > 1 month).

Background

This project aimed to improve education and training in the field of Radioligand Therapy. This field is an innovative field consisting of administration of radioactive drugs (“radiopharmaceuticals”) to combat cancer, with a strong increase in approved drugs and potential patients expected in the coming years. Increasing the skills and the number of trained professionals involved in preparation and administration is crucial. There is a strong need to understand how RLT is currently incorporated in training curricula and how they can be improved to increase the knowledge about RLT. Furthermore, there is a lack of online tools to learn about RLT and there is no organized framework that allows healthcare providers to get practical exposure to RLT. Finally, there are many obstacles that impede the implementation of RLT and we there is a clear need of guidance from experts from the field to guide policymakers so that they can address the needs of the field and remove barriers for adaption, so that all European eligible patients can get access to the treatment.

Project partners (11)